Strontium-substituted hydroxyapatite coatings synthesized by pulsed-laser deposition: in vitro osteoblast and osteoclast response.
The increasing interest in strontium incorporation into biomaterials for hard tissue repair is justified by the growing evidence of its beneficial effect on bone. We successfully synthesized hydroxyapatite (HA) thin films with different extents of strontium substitution for calcium (0, 1, 3 or 7 at.%) by pulsed-laser deposition. The coatings displayed a granular surface and a good degree of crystallinity, which slightly diminished as strontium content increased. Osteoblast-like MG63 cells and human osteoclasts were cultured on the thin films up to 21 days. MG63 cells grown on the strontium-doped HA coatings displayed normal morphology, good proliferation and increased values of the differentiation parameters, whereas the number of osteoclasts was negatively influenced by the presence of strontium. The positive effect of the ion on bone cells was particularly evident in the case of coatings deposited from HA at relatively high strontium contents (3-7%), where significantly increased values of alkaline phosphatase activity, osteocalcin, type I collagen and osteoprotegerin/TNF-related activation-induced cytokine receptor ratio, and considerably reduced values of osteoclast proliferation, were observed.
Capuccini
C
C
Department of Chemistry G. Ciamician, University of Bologna, 40126 Bologna, Italy.
Torricelli
P
P
Sima
F
F
Boanini
E
E
Ristoscu
C
C
Bracci
B
B
Socol
G
G
Fini
M
M
Mihailescu
I N
IN
Bigi
A
A
D000469:Alkaline Phosphatase / Q000378:metabolism; D001672:Biocompatible Materials / Q000737:chemistry*; D002118:Calcium / Q000737:chemistry; D002454:Cell Differentiation; D049109:Cell Proliferation; D024042:Collagen Type I / Q000737:chemistry; D006801:Humans; D006882:Hydroxyapatites / Q000737:chemistry*; D066298:In Vitro Techniques; D007834:Lasers; D053758:Nanoparticles / Q000737:chemistry; D036103:Nanotechnology / Q000379:methods; D010006:Osteoblasts / Q000378:metabolism*; D015675:Osteocalcin / Q000737:chemistry; D010010:Osteoclasts / Q000378:metabolism*; D053244:Osteoprotegerin / Q000737:chemistry; D013324:Strontium / Q000737:chemistry*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D001672:Biocompatible Materials; D024042:Collagen Type I; D006882:Hydroxyapatites; D053244:Osteoprotegerin; D014409:Tumor Necrosis Factor-alpha; C076185:strontium hydroxyapatite; D015675:Osteocalcin; D000469:Alkaline Phosphatase; D002118:Calcium; D013324:Strontium